Skip to content

Clinical trials

Philadelphia Chromosome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Philadelphia Chromosome Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20041
20051
20064
20081
20091
20102
20114
20123
20131
20141
20151
20172
20181
20191
20211
20223
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Active, not recruiting2
Recruiting2
Unknown status2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
M.D. Anderson Cancer Center3
Pfizer3
Il-Yang Pharm. Co., Ltd.2
Nanfang Hospital, Southern Medical University2
National Cancer Institute (NCI)2
Assistance Publique - Hôpitaux de Paris1
Bristol-Myers Squibb1
Chinese Academy of Medical Sciences1
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Philadelphia Chromosome35
Leukemia, Myelogenous, Chronic, BCR-ABL Positive22
Precursor Cell Lymphoblastic Leukemia-Lymphoma16
Leukemia11
Leukemia, Myeloid4
Leukemia, Myeloid, Acute4
Hematologic Diseases3
Lymphoma3
Lymphoma, Non-Hodgkin3
Neoplasm, Residual3

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.